4 employees
Allon Therapeutics is a clinical-stage biopharmaceutical company, engaged in the development of drugs to treat neurodegenerative diseases.
2001
$10M
from 1 investors over 1 rounds
Allon Therapeutics raised $10M on March 3, 2010
Investors: Yorkville Advisors